Jeffrey James Ross - Jun 28, 2021 Form 4/A - Amendment Insider Report for Miromatrix Medical Inc. (MIRO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Steven J. Conley, Attorney-in-Fact
Stock symbol
MIRO
Transactions as of
Jun 28, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/18/2022, 06:10 PM
Date Of Original Report
Jun 29, 2021
Previous filing
Jun 23, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRO Common Stock Conversion of derivative security $0 +4.4K +2.16% $0.00 208K Jun 28, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRO Series B Preferred Stock Conversion of derivative security -4.4K -100% 0 Jun 28, 2021 Common Stock 4.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
F2 The reporting person's Form 4 filed on June 29, 2021 inadvertently understated the reporting person's direct holdings by 203,750 shares.